李-佛美尼综合征中胃肠道肿瘤的谱系与超额风险
Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-09-14
本文综述李-佛美尼综合征(LFS)与TP53胚系致病变异相关的高癌症风险,指出结直肠癌占诊断的约2.8%,胃癌和食管癌合计占1.3%。
要点
- LFS由TP53胚系致病变异引起,癌症风险极高。
- 结直肠癌在核心癌和血液系统肿瘤之后最常见,约占2.8%。
- 胃癌和食管癌合计约占1.3%。
核心结论
- LFS与TP53胚系致病变异相关,癌症风险极高,结直肠癌占诊断的约2.8%,胃癌和食管癌合计占1.3%。
主要发现
- 结直肠癌在核心癌和血液系统肿瘤之后最常见,约占诊断的2.8%。
- 胃癌和食管癌合计约占诊断的1.3%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Li-Fraumeni syndrome (LFS), linked to heterozygous germline pathogenic/likely pathogenic variants in TP53, confers exceptionally high cancer risk, including core cancers (sarcoma, breast, adrenocortical, and brain cancer) among many other cancer types.1 Colorectal cancer (CRC) is most common after the core and hematologic cancers, accounting for ∼2.8% of diagnoses. Stomach and esophageal cancers constitute another 1.3% (TP53 Database; R20, July 2019: https://tp53.isb-cgc.org).2.
来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。
引用
- Hatton JN, de Andrade KC, Frone MN, et al. Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome. Clin Gastroenterol Hepatol. 2023. PMID: 37714395. doi:10.1016/j.cgh.2023.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。